VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Adagene's ADG138 NDA Accepted by China's NMPA — Stock Volatility Signals Renewed Market Interest
Adagene's ADG138 NDA Accepted by China's NMPA — Stock Volatility Signals Renewed Market Interest
May 30, 2026 05:59 CST Updated 07:15
Share:
Adagene
Developer of Novel Cancer Immunotherapies